Cover image of the article: Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

Image Credit:Hepat Mon

Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

Authors

Masoomeh Sofian1, Arezoo Aghakhani2, Ali Asghar Asghar Farazi1, Mohammad Banifazl3, Ali Eslamifar2, Niloofar Rashidi2, Akbar Khadem Sadegh2, Amitis Ramezani2,*
1Tuberculosis and Pediatric Infectious Research Center (TPIRC), Arak University of Medical Sciences, IR Iran
2Clinical Research Department, Pasteur Institute of Iran, amitisramezani@hotmail.com, IR Iran
3Iranian Society for Support of Patients With Infectious Diseases, IR Iran
*Corresponding Author: Clinical Research Department, No 69, Pasteur Ave., 13164, amitisramezani@hotmail.com, IR Iran. Tel: +98-2166968852. Fax: +98-2166465147. Email: amitisramezani@hotmail.com

Hepatitis Monthly:Vol. 12, issue 12; 6156
Published online:Dec 29, 2012
Article type:Research Article
Received:May 20, 2012
Accepted:Jun 15, 2012
How to Cite:Sofian M, Aghakhani A, Farazi AA, Banifazl M, Eslamifar A, et al. Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients. Hepat Mon. 2012;12(12):6156. doi: https://doi.org/10.5812/hepatmon.6156

Abstract

Background:

T-helper (Th) lymphocyte cytokine production may be important in the immune pathogenesis of hepatitis C virus (HCV) infections. Th1 cytokines such as; interleukin- 2 (IL-2), and interferon gamma (IFN-gamma) are necessary for host antiviral immune responses, while Th2 cytokines (IL-4, IL-10) can inhibit the development of these effector mechanisms.

Objectives:

The aim of the present study was to assess the serum profile of Th1 and Th2 cytokines in treated and non-treated HCV infected individuals.

Patients and Methods:

This study was carried out in 63 HCV infected patients (31 under treatment and 32 untreated) and 32 matched HCV-sero negative healthy subjects. Serum samples were checked with an enzyme-linked immune sorbent assay (ELISA) for IL-2, IL-4, IL-10 and IFN-gamma.

Results:

Levels of circulating IL-2, IL-4, IL-10 and IFN-gamma were significantly elevated in HCV patients versus normal controls (2 822.6 1 259.92 vs. 950.8 286.9 pg/mL; 1 987 900.69 vs. 895.91 332.33 pg/mL; 1 688.5 1 405.1 vs. 519.03 177.64 pg/mL and 1 501.9 1 298 vs. 264.66 71.59 pg/mL, respectively; P < 0.001). The serum levels of all cytokines were significantly lower in the patients under treatment than those of the untreated patients (P < 0.001).

Conclusions:

On the basis of our data, the simultaneous increase of Th1 and Th2 related cytokines may indicate that both Thl and Th2 cytokines are involved in the pathogenesis of HCV infections. Moreover, this activated T-cell response in HCV infected patients may be regulated by treatment.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Jan
2007
Th1 Cytokine Profiles in Hepatitis C Virus Infected Patients and  Their Contribution to Inflammatory Responses

Th1 Cytokine Profiles in Hepatitis C Virus Infected Patients and Their Contribution to Inflammatory Responses

M Najafizadeh,
N Farhadi,
B Sarkari

Najafizadeh M, Farhadi N, Sarkari B. Th1 Cytokine Profiles in Hepatitis C Virus Infected Patients and Their Contribution to Inflammatory Responses. Shiraz E-Med J. 2007;8(1):. doi:

30
Apr
2018
Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection

Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection

Seyed Hedayat Hosseini Khorami,
Foroogh Nejatollahi,
Mohammad Ali Davarpanah

Hosseini Khorami SH, Nejatollahi F, Davarpanah MA. Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection. Hepat Mon. 2018;18(4):e60377. doi: https://doi.org/10.5812/hepatmon.60377

27
Sep
2014
Analytical Assessment of Interleukin - 23 and -27 Cytokines in Healthy People and Patients With Hepatitis C Virus Infection (Genotypes 1 and 3a)

Analytical Assessment of Interleukin - 23 and -27 Cytokines in Healthy People and Patients With Hepatitis C Virus Infection (Genotypes 1 and 3a)

Asghar Ashrafi Hafez,
Abbas Ahmadi Vasmehjani,
Rasoul Baharlou,
Seyed Dawood Mousavi Nasab,
Mohammad Hasan Davami,
Ahmad Najafi
,et al.

Ashrafi Hafez A, Ahmadi Vasmehjani A, Baharlou R, Mousavi Nasab SD, Davami MH, et al. Analytical Assessment of Interleukin - 23 and -27 Cytokines in Healthy People and Patients With Hepatitis C Virus Infection (Genotypes 1 and 3a). Hepat Mon. 2014;14(9):e21000. doi: https://doi.org/10.5812/hepatmon.21000

21
May
2013
Controversial Concepts Regarding T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

Controversial Concepts Regarding T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

Mojgan Noroozi Karimabad,
Gholamhossein Hassanshahi,
Mohammad Kazemi Arababadi

Noroozi Karimabad M, Hassanshahi G, Kazemi Arababadi M. Controversial Concepts Regarding T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients. Hepat Mon. 2013;13(5):e8067. doi: https://doi.org/10.5812/hepatmon.8067

30
Jun
2009
Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy

Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy

Amir Ziaee,
Fatemeh Esfehanian,
Majid Sarreshtedari

Ziaee A, Esfehanian F, Sarreshtedari M. Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy. Hepat Mon. 2009;9(2):. doi:

More by these authors

Masoomeh SofianPubMedScholar
Arezoo AghakhaniPubMedScholar
Ali Asghar FaraziPubMedScholar
Mohammad BanifazlPubMedScholar
Ali EslamifarPubMedScholar
Niloofar RashidiPubMedScholar
Akbar Khadem SadeghPubMedScholar
Amitis RamezaniPubMedScholar
Share
Cited by
Metrics